(Q43502352)
Statements
1 reference
Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO. (English)
1 reference
1 reference
Linch D
1 reference
Mainwaring PN
1 reference
Gregory W
1 reference
Hoskin P
1 reference
Hancock B
1 reference
Norton AJ
1 reference
MacLennan K
1 reference
Smith P
1 reference
Hudson GV
1 reference
1 May 2001
1 reference
1 reference
97
1 reference
10
1 reference
2991-2997
1 reference
Identifiers
1 reference
1 reference